Cart
sales@molnova.com
TLR7/8/9-IN-1
CAS No. 2180127-82-4
TLR7/8/9-IN-1( —— )
Catalog No. M28232 CAS No. 2180127-82-4
TLR7/8/9-IN-1 is a potent inhibitor of Toll-like receptors 7/8/9 (TLR7/8/9) with an IC50 of 43 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 169 | In Stock |
|
| 2MG | 64 | In Stock |
|
| 5MG | 113 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 307 | In Stock |
|
| 50MG | 439 | In Stock |
|
| 100MG | 597 | In Stock |
|
| 200MG | 853 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTLR7/8/9-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTLR7/8/9-IN-1 is a potent inhibitor of Toll-like receptors 7/8/9 (TLR7/8/9) with an IC50 of 43 nM.
-
DescriptionTLR7/8/9-IN-1 is a potent inhibitor of Toll-like receptors 7/8/9 (TLR7/8/9) with an IC50 of 43 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
Recptor5-LOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2180127-82-4
-
Formula Weight435.6
-
Molecular FormulaC27H37N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (191.30 mM)
-
SMILESCC(C)c1c(-c(cc2)cc(OC)c2OC)[nH]c2c1cc(C1CCN(CCNC)CC1)cc2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matthew Hutzler J, et al. In vitro-in vivo correlation and translation to the clinical outcome for CJ-13,610, a novel inhibitor of 5-lipoxygenase. Drug Metab Dispos. 2010 Jul;38(7):1113-21.
molnova catalog
related products
-
Semapimod hydrochlor...
Semapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production.
-
CL264
CL264, a specific agonist of TLR7, is used for innate immune signals research.
-
CPG-52364
CPG-52364 (CPG52364) is an orally available, small molecule TLR7/8/9 antagonist for the treatment of systemic lupus erythematosus and other autoimmune disorders.
